zidovudine in English
The drug is indicated for use in patients unresponsive to or intolerant of zidovudine , zalcitabine, or didanosine.
Use "zidovudine" in a sentence
1. What does Azidothymidine mean? Zidovudine
2. Zidovudine (Azidothymidine, AZT) is a thymidine analogue
3. We have been able to measure intracellular zidovudine triphosphate (the active Anabolite of zidovudine) in peripheral blood mononuclear cells from healthy volunteers given small doses of 14C-zidovudine, and have directly compared the sensitivity of AMS to traditional LC/MS methods carried out in our laboratory.
4. Zidovudine, also known as Azidothymidine (AZT), was the first antiviral to be approved for the treatment of HIV.Although no longer a first-line agent, zidovudine is still used in combination with other ARVs for the treatment of HIV [39].Zidovudine is an NRTI that undergoes intracellular
5. Alternative Titles: Retrovir, Azidothymidine, zidovudine AZT, in full azidothymidine, also called zidovudine, drug used to delay development of AIDS (acquired immunodeficiency syndrome) in patients infected with HIV (human immunodeficiency virus)
6. Azt, also called Zidovudine (ZVD) and Retrovir, was the first approved HIV/AIDS drug
7. "HIV with reduced sensitivity to zidovudine (Azt isolated during prolonged therapy." Science
8. Azt triphosphate (3'-Azido-3'-deoxythymidine-5'-triphosphate) is a active triphosphate metabolite of Zidovudine (Azt)
9. Azidothymidine (AZT, also called Zidovudine) is a nucleoside analog reverse-transcriptase inhibitor useful against the HIV virus
10. Zidovudine (ZDV), also known as Azidothymidine (AZT), is an antiretroviral medication used to prevent and treat HIV/AIDS
11. Azidothymidine: see AZT AZT or zidovudine, drug used to treat patients infected with the human immunodeficiency virus (HIV), which causes AIDS; also called Azidothymidine
12. Summary Retrovir (zidovudine, ZDV, formerly called Azt) is a medication (oral and injectable) prescribed for the treatment of infections with HIV (human immunodeficiency virus)
13. The first effective antiviral compound (AZT, Azidothymidine, zidovudine) was already among the library of compounds screened and was promptly reported to be a specific inhibito …
14. Antiviral drug Azidothymidine 63, known also as AZT and zidovudine, is useful in treatment of AIDS as an agent impeding the human immunodeficiency virus replication process
15. ‘Although the sulfated maitake fraction resembled the anti-HIV potency of AZT (zidovudine, formerly Azidothymidine), it was not considered a promising treatment because of potential cellular toxicity in vivo.’.
16. In 1964, Jerome Horwitz synthesized the drug zidovudine, commonly abbreviated ZDV, otherwise known as Azidothymidine, or AZT, at Wayne State University School of Medicine in Detroit, Michigan
17. Definition of Azt : an antiviral drug C10H13N5O4 that inhibits replication of some retroviruses (such as HIV) and is used to treat AIDS — called also azidothymidine, zidovudine First Known Use of Azt
18. The first effective antiviral compound (Azt, azidothymidine, zidovudine) was already among the library of compounds screened and was promptly reported to be a specific inhibitor of retroviruses, including HIV.
19. Zidovudine (Azidothymidine, AZT) is a nucleoside analog reverse-transcriptase inhibitor (NRTI), a type of antiretroviral drug used for the treatment of HIV/AIDS infection.;IC50 value:;Target: NRTI; reverse-transcriptaseAZT is a thymidine analogue.
20. Azt, in full azidothymidine, also called zidovudine, drug used to delay development of AIDS (acquired immunodeficiency syndrome) in patients infected with HIV (human immunodeficiency virus). Azt belongs to a group of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs).
21. Zidovudine (Retrovir or Azidothymidine [AZT]) was approved in March 1987 as the first antiviral therapy for HIV disease, when a clinical thai of ZDV versus placebo in patients with advanced disease was terminated early based on evidence of improved survival (Fischl, Richman, Grieco, et al.
22. The conjugated medicinal agent of the present invention has the following formula (I): P-(S)x-Gal-GA-R, wherein in the P-(S)x-moiety, P is a peptide residue of a human serum glycoprotein and S is a sugar residue of a human serum glycoprotein; Gal is galactose residue; GA is glutaraldehyde residue; x is an integer equal to or greater than 1; and R is a medicinal component selected from the group consisting of interferon, acyclovir sodium, ribavirin, vidarabine, zidovudine, suramin, anti-sense oligonucleotide, ribozyme, leucovorin calcium, sodium-meglumine diatrizoate, gadolinium-DTPA, glutathione (GSH), prostaglandins, ?